Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Scout Bio Inc. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The portfolio is currently assigned to 1 distinct examiner and 1 distinct art unit, reflecting a narrow and specific area of biotechnology focus. This point of contact within the patent office simplifies the management of the company's intellectual property. However, it also means that the company's current success depends on the findings and technical interpretation of 1 examiner.
The busiest examiner, GROOMS, TIFFANY NICOLE, is handling the 1 busiest examiner pending office action. This examiner is the person responsible for the company's 1 pending office action, making their examination style the primary factor in the prosecution process. Because there is 1 distinct examiner and 1 distinct art unit, the company does not have to navigate different procedural standards or technical perspectives. The focus of the prosecution effort should be on resolving the specific issues raised by this 1 examiner to clear the 1 pending office action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GROOMS, TIFFANY NICOLE | 1 | 57.8% | +46.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18033279 | METHOD OF SUPPRESSING IMMUNE RESPONSE TO VECTOR-DELIVERED THERAPEUTIC PROTEIN | GROOMS, TIFFANY NICOLE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18033279 | METHOD OF SUPPRESSING IMMUNE RESPONSE TO VECTOR-DELIVERED THERAPEUTIC PROTEIN | GROOMS, TIFFANY NICOLE | — |
| Art Unit | Apps |
|---|---|
| 1637 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18033279 | METHOD OF SUPPRESSING IMMUNE RESPONSE TO VECTOR-DELIVERED THERAPEUTIC PROTEIN | GROOMS, TIFFANY NICOLE | 1637 | §102§103§112 | Non-Final OA | — | Pending | Apr 21, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial